[1]
Hanna, L. et al. 2025. Expert opinion on the management of anemia in prostate cancer patients receiving PARP inhibitors. Canadian Urological Association Journal. 19, 12 (Dec. 2025), 422–31. DOI:https://doi.org/10.5489/cuaj.9401.